SEC Form 4 · accession 0001171843-15-006650

IMMUNOMEDICS INC · IMMU

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Dec 1, 2015

Accepted (ET)

Dec 4, 2015 · 8:55 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000722830

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Dec 1, 2015	M	10,000	$1.59	A	65,738	D
Common Stock	Dec 1, 2015	F	6,262	$3.17	D	59,476	D
Common Stock^F1	Dec 1, 2015	M	10,664	—	A	70,140	D
Common Stock^F2	Dec 1, 2015	F	2,666	—	D	67,474	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options (right to buy)^F3	$1.59	Dec 1, 2015	M	10,000	D	—	Dec 3, 2015	Common Stock, par value $0.01 per share	10,000	0	D
Restricted Stock Units^F4	—	Dec 1, 2015	M	10,664	D	—	—	Common Stock, par value $0.01 per share	10,664	0	D
Stock Options (right to buy)^F3	$3.11	Dec 2, 2015	A	28,821	A	—	Dec 2, 2022	Common Stock, par value $0.01 per share	28,821	28,821	D
Restricted Stock Units^F4	—	Dec 2, 2015	A	14,469	A	—	—	Common Stock, par value $0.01 per share	14,469	14,469	D

F1Delivery of common stock upon vesting of restricted stock units granted on December 3, 2014.
F2The number of shares withheld to satisfy the tax withholding obligation of the reporting person upon vesting of Restricted Stock Units is correlated with the reporting person's tax withholding percentage.
F3The stock options are fully vested on the date of grant.
F4Each restricted stock unit represents a contingent right to receive one share of Immunomedics, Inc. common stock. The restricted stock units shall vest upon the earlier of (i) the reporting person's completion of one year of service as a non-employee director from the date of grant, or (ii) the reporting person's continuation in service through the day immediately preceding the next annual stockholders meeting following the date of grant.